β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial-Reference-Cited by-同舟云学术

β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

Published:2001-11 Issue:9295 Volume:358 Page:1749-1753
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Raz Itamar,Elias Dana,Avron Ann,Tamir Merana,Metzger Muriel,Cohen Irun R

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Insulin-dependent diabetes mellitus as an autoimmune disease;Bach;Endocr Rev,1994

2. Breeding of a non-obese, diabetic strain of mice;Makino;Exp Anim,1980

3. T-cell responses to autoantigens in IDDM: the search for the Holy Grail;Roep;Diabetes,1996

4. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/LT) mouse by a 65-kDa heat shock protein;Elias;Proc Natl Acad Sci USA,1990

5. Peptide therapy for diabetes in NOD mice;Elias;Lancet,1994

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryo-EM structure and molecular dynamic simulations explain the enhanced stability and ATP activity of the pathological chaperonin mutant;Structure;2024-05

2. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials;Diabetes/Metabolism Research and Reviews;2024-05

3. Mathematical model for BCG-based treatment of type 1 diabetes;Physica A: Statistical Mechanics and its Applications;2023-07

4. Diabetes in Children and Adolescents;The Diabetes Textbook;2023

5. Teplizumab in Type 1 Diabetes Mellitus: An Updated Review;touchREVIEWS in Endocrinology;2023